Dr. Janine Austin Clayton is the Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health. There are 27 Institutes and Centers at the National Institutes of Health (NIH). Research on women’s health is being conducted across all of these Institutes, and Janine helps lead and coordinate these efforts. In addition, she champions and celebrates the exceptional work that NIH-supported researchers around the world are doing. Janine’s own research focuses on issues in women’s health and diseases of the eye. Janine has a wide variety of interests outside of science, including visiting art museums near her home in Washington DC and around the world. She also likes spending her free time hanging out with her family, listening to jazz music, playing the piano, reading the Sunday paper, and staying active through yoga, Tai Chi, and Zumba. She was awarded her undergraduate degree with honors from Johns Hopkins University and her medical degree from Howard University College of Medicine. Afterwards, Janine completed a residency in ophthalmology at the Medical College of Virginia and fellowships at the Wilmer Eye Institute at Johns Hopkins Hospital as well as the National Eye Institute (NEI). Janine is a board-certified ophthalmologist. She served as a Clinical Investigator at NEI for a number of years, and prior to her current appointments, she was the Deputy Clinical Director of NEI. Janine has received numerous awards and honors for her exceptional work, including the Senior Achievement Award from the Board of Trustees of the American Academy of Ophthalmology, selection as a Silver Fellow by the Association for Research in Vision and Ophthalmology, the European Uveitis Patient Interest Association Clinical Uveitis Research Award, the American Medical Women’s Association Lila A. Wallis Women’s Health Award, the Wenger Award for Excellence in Public Service, and the Bernadine Healy Award for Visionary Leadership in Women’s Health. In addition, Janine was selected as an honoree for the Woman’s Day Red Dress Awards and the American Medical Association’s Dr. Nathan Davis Awards for Outstanding Government Service. In our interview, Janine speaks more about her experiences in life and science.

Direct download: 482_Janine_Austin_Clayton.mp3
Category:general -- posted at: 3:00am EDT

Dr. Joseph S. Takahashi is Professor and Chair of Neuroscience and the Loyd B. Sands Distinguished Chair in Neuroscience at the University of Texas Southwestern Medical Center. He is also an Investigator in the Howard Hughes Medical Institute. Joe and his lab members are trying to better understand the biological clocks in our bodies that control our 24-hour schedules. A special set of genes within nearly all of our cells turns on and off each day to regulate a wide variety of biological functions, and Joe is studying these genes and how they contribute to our biological rhythms. When Joe isn’t at work, he enjoys playing tennis, skiing, hiking, eating delicious food, and drinking great wine. Joe received his B.A. in biology from Swarthmore College and he was awarded his Ph.D. in neuroscience from the University of Oregon in Eugene. Afterwards, he conducted postdoctoral research as a pharmacology research associate at the National Institute of Mental Health. Before moving to UT Southwestern, Joe served on the faculty of Northwestern University for 26 years. Over the course of his career, Joe has received numerous awards and honors including the Honma Prize in Biological Rhythms Research, the NSF Presidential Young Investigator Award, the Searle Scholars Award, the Bristol-Myers Squibb Unrestricted Grant in Neuroscience, the C. U. Ariens Kappers Medal, the Outstanding Scientific Achievement Award from the Sleep Research Society, the W. Alden Spencer Award in Neuroscience from Columbia University, and the Peter C. Farrell Prize in Sleep Medicine from the Harvard Medical School Division of Sleep Medicine. He has also been elected as a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, a Member of the National Academy of Sciences, a Member of the National Academy of Medicine, and an Honorary Member of The Japanese Biochemical Society. In our interview, Joe shared his experiences in life and science.

Direct download: 481_Joseph_Takahashi_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Barbara Katzenback is an Assistant Professor in the Department of Biology at the University of Waterloo. Amphibian populations are declining worldwide, and one reason for their decline is their susceptibility to diseases that are emerging in their environments. Barb studies how frogs defend themselves from diseases to stay alive, and she also investigates how the environments that frogs live in impact their ability to defend against diseases. Barb’s hobbies outside of science include engaging in a variety of physical activities like running, yoga, and hiking with her husband and two dogs. She’s also experimented with soccer, spin classes, cross country skiing, rock climbing, and inner tube water polo. Some of her other interests include pottery, art, crafting, baking, gardening, sewing, and leisure reading. Barb earned her BSc with Honors in Immunology and Infection from the University of Alberta. She received her PhD in Physiology, Cell, and Developmental Biology from the University of Alberta as well. Barb was next awarded a Natural Sciences and Engineering Research Council (NSERC) Postdoctoral Fellowship to conduct research at Carleton University, followed by an NSERC Banting Postdoctoral Fellowship to conduct research at the University of Waterloo before joining the faculty there. In our interview, Barb speaks more about her experiences in life and science.

Direct download: 480_Barb_Katzenback_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Robert A. Beardsley or "Al" is a Co-Founder and the Chief Operating Officer at Galera Therapeutics, a clinical-stage biotech company discovering and developing innovative cancer treatments. Al is interested in developing new drugs that target how oxygen is metabolized in cells. In particular, Al and the team at Galera Therapeutics are working to develop therapeutics to use with radiation therapy that will block the processes that cause damage to normal tissue while also increasing damage to the tumor. While Al is passionate about science and drug development, he also enjoys watching soccer, coaching soccer, being outdoors, and hiking in the mountains in his free time. Al received his BS in Chemical Engineering from the University of Iowa, an MBA in finance from the University of Chicago, and subsequently his PhD in Biochemical Engineering from the University of Iowa. Prior to co-founding Galera Therapeutics, Al served as CEO at Metabolic Solutions Development Corporation, CEO of Kereos, acting CEO at Metaphore Pharmaceuticals, and he has held various roles at Confluence Life Sciences, SImile Investors, bioStrategies Group, and Vector Securities International. Galera Therapeutics’ new drug Abasopasem Manganese has been designated as a “Breakthrough Therapy” by the FDA for reduction in the duration, incidence, and severity of oral mucositis induced by radiation therapy in cancer patients. Recently, Al and the team at Galera Therapeutics raised $150 million in investment for their company, which represents the largest single capital round ever raised by a life-sciences company founded in St. Louis. In this podcast interview, Al spoke with us about his experiences in life and science.

Direct download: 479_Al_Beardsley_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Chad Orzel is the R. Gordon Gould Associate Professor of Physics at Union College. He is also author of the popular science books How to Teach Physics to Your Dog, How to Teach Relativity to Your Dog, Eureka: Discovering Your Inner Scientist, and the soon-to-be-released book Breakfast with Einstein: The Exotic Physics of Everyday Objects. In addition, Chad regularly contributes blog articles for Forbes Magazine. Chad studies ultracold atoms to improve our understanding of atomic physics. He uses lasers to drop the temperature of samples of atoms to just millionths or billionths of a degree above absolute zero. At these very cold temperatures, the atoms are moving very slowly, and interesting quantum effects arise. Free time can be hard to find with two kids and a puppy at home, but Chad enjoys hanging out with his family, reading science fiction and fantasy books, and playing basketball during his lunch hour at work. Chad received his B.A. in Physics from Williams College and his Ph.D. in Chemical Physics from the University of Maryland. Before joining the faculty at Union College, Chad conducted postdoctoral research in the Physics Department at Yale University. In our interview, Chad shared his experiences from his life and science.

Direct download: 487_Chad_Orzel_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Allison Okamura is a Professor of Mechanical Engineering at Stanford University. She also holds a courtesy appointment in Computer science there. Research in Allison’s lab examines three different areas of robotics. The first is haptics, which involves human machine interactions through the sense of touch. The second is designing medical robots that can, for example be used to help people recover from stroke or perform surgery. A final area that Allison studies is creating soft robots that can conform to their environments. Much of Allison’s free time is spent with her husband, daughter, and son. When she’s not at work, Allison also enjoys relaxing, running, and playing ice hockey. Allison received her B.S. in Mechanical Engineering from the University of California, Berkeley, and she was awarded her M.S. and Ph.D. both in Mechanical Engineering from Stanford University. Before joining the faculty at Stanford University, Allison was Professor and Vice Chair of Mechanical Engineering at Johns Hopkins University. Allison is the recipient of numerous awards and honors, including being elected as a fellow for the Institute of Electrical and Electronics Engineers (IEEE). She has also been awarded the IEEE Technical Committee on Haptics Early Career Award, the IEEE Robotics and Automation Society Early Academic Career Award, and an NSF CAREER Award. In addition, Allison was honored as a Duca Family University Fellow in Undergraduate Education, a Robert Bosch Faculty Scholar, a Gabilan Fellow, and an Alumni Distinguished Scholar by Stanford University, as well as a Decker Faculty Scholar by Johns Hopkins University. In our interview, Allison speaks more about her experiences in life and science.

Direct download: 477_Allison_Okamura_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Mario Thevis is Vice President of Research, Professor, and head of the Centre for Preventive Doping Research at the German Sport University of Cologne. He is also Director of the European Monitoring Center for Emerging Doping Agents (EuMoCEDA), a forensic chemist, Editor and Chief of the journal Drug Testing and Analysis, and a Research Scientist with the Partnership for Clean Competition. Mario’s time in the lab is split between research and performance of routine doping control work. On the research side, he is developing novel means and analytical methods to test athletes for the use of banned substances and methods of doping. Substances tested for include stimulants, steroids, blood doping, and others. The routine doping control side of Mario’s work involves testing samples for banned substances and investigating positive test cases. When he’s not working in the lab, Mario enjoys spending time with his family and watching soccer matches. He received his undergraduate education in organic chemistry from RWTH Aachen University as well as in sports sciences from the German Sport University of Cologne. Mario went on to earn his PhD in biochemistry from the German Sport University of Cologne. Afterwards, Mario conducted postdoctoral research at the University of California, Los Angeles. He served as a senior researcher at the German Sport University Cologne for a few years before being appointed Professor for Preventive Doping Research there. In our interview Mario will tell us more about his life and science.

Direct download: 476_Mario_Thevis_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Dennis Riley is Co-Founder and Chief Scientific Officer at Galera Therapeutics, a clinical-stage biotech company discovering and developing innovative cancer treatments. He is also an Adjunct Professor of Chemistry at Washington University in St. Louis. Dennis and his colleagues have been developing synthetic enzymes that target undesired or toxic metabolic byproducts. One compound Dennis has developed protects healthy tissue from radiation damage during cancer treatment. When he’s not doing work, Dennis enjoys mountain biking, golfing, and amateur astronomy. He earned his Bachelor’s degree in chemistry and mathematics from Heidelberg College and his PhD in inorganic chemistry from The Ohio State University. Afterwards, Dennis conducted postdoctoral research at the University of Chicago. Dennis began his career working in research and development with Proctor and Gamble, and he spent much of his career working at Monsanto where he held the positions of Senior Science Fellow and Manager of Metal-Mediated Chemistry. He subsequently served as Vice President of Research at Metaphore Pharmaceuticals and Senior Vice-President at the start-up company Kereos before co-Founding Galera Therapeutics. Dennis is an elected Fellow of the American Association for the Advancement of Science and he has received the American Chemical Society St. Louis Section’s Chemist of the Year Award. In addition, Galera Therapeutics’ new drug GC4419 has been designated as a “Breakthrough Therapy” by the FDA for reduction in the duration, incidence, and severity of oral mucositis induced by radiation therapy in cancer patients. In this podcast interview, Dennis spoke with us about his experiences in life and science.

Direct download: 475_Dennis_Riley_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Kathryn (Katie) Whitehead is an Assistant Professor in Chemical Engineering at Carnegie Mellon University where she also holds a courtesy appointment in Biomedical Engineering. Research in Katie’s lab group focuses on therapeutic drug delivery. Their goal is to make the process of drug delivery more efficient by sending medicine only to the specific parts of the body where they are needed. Katie is also working to create new precision medicines using RNA and DNA and to develop the drug delivery systems for these future medicines. Since she was a PhD student, Katie has been interested in gardening. She started with just a single tomato plant, and now she grows over 20 different varieties of heirloom tomatoes, as well as other vegetables, fruits, and berries. Katie received her bachelor’s degree in chemical engineering from the University of Delaware and her PhD in chemical engineering from the University of California, Santa Barbara. Afterwards, she conducted postdoctoral research in the Koch Institute for Integrative Cancer Research at MIT. Katie has received numerous awards and honors, including the DARPA Young Faculty Award, the DARPA Director’s Fellowship, the Controlled Release Society Capsugel/Pfizer Oral Drug Delivery Award, the Diabetes Technology Society Peterson Research Award, a UC Graduate Research and Education in Adaptive Biotechnology Fellowship, an NIH Ruth Kirschstein National Research Service Award Fellowship, the Kun Li Award for Excellence in Education, the Popular Science Brilliant 10 Award, and very recently the 2018 National Institutes of Health (NIH) Director’s New Innovator Award. She has also been named an MIT Technology Review Innovator Under 35 and the 2016 Young Innovator Award from Cellular and Molecular Bioengineering (CMBE). In our interview, Katie speaks more about her experiences in life and science.

Direct download: 474_Katie_Whitehead_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Satesh Bidaisee is a Professor of Public Health and Preventative Medicine and Assistant Dean for Graduate Studies at St. George’s University in Grenada. He is also an Adjunct Professor in the Center for Global Health at Old Dominion University and a Visiting Professor at Chitkara University in India and at Kasetsart University in Thailand. Many aspects of human health are linked with conditions in our environment. Satesh’s research aims to identify and understand environmental factors that can impact human health, both positively and negatively. One of Satesh’s passions outside of science is aviation. He has been fascinated by aircraft since childhood, and for the past decade, Satesh has enjoyed flying throughout the Caribbean region as a private pilot. Satesh received his Doctor of Veterinary Medicine Degree (D.V.M.) from the University of the West Indies, St. Augustine Campus, a Master’s of Science (M.S.) degree in Public Health from St. George’s University, and a Doctor of Education Degree (Ed.D.) from the University of Sheffield. Prior to joining the faculty at St. George’s University, Satesh held positions at the University of Trinidad and Tobago as well as the Ministry of Health in Trinidad and Tobago. Satesh is a Fellow of the Royal Society of Public Health, the Royal Society of Tropical Medicine and Hygiene, the International Society on Infectious Diseases, and the Society of Biology. He is also board certified by the United States National Board of Public Health Examiners. In our interview, Satesh shared his experiences in life and science.

Direct download: 473_Satesh_Bidaisee_Final.mp3
Category:general -- posted at: 3:00am EDT



-->

Syndication

Categories

Archives

March 2018
S M T W T F S
     
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31